May 20, 2019 / 05:00PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Okay. Thanks for joining us for our first session here after lunch. I am Matt Taylor, the U.S. medical supplies and devices analyst here at UBS. And I'm joined by management from Baxter, including Jay Saccaro, who's the EVP and Chief Financial Officer; and Clare Trachtman, VP of Investor Relations.
So I just want to start out here and give Jay a chance to make some opening comments about Baxter. And then we'll move through a fireside chat Q&A format. And just want to remind everyone that we're going to do some interactive questions. So you haven't downloaded the app, it's a UBS conference app, where you can look at the Q&A portion of each session. And I'll ask questions throughout the fireside chat.
But first, Jay, why don't you get started and make some opening comments. And then we'll get right into it.
James K. Saccaro - Baxter International Inc. - Executive VP & CFO
Great, Matt. Thanks for inviting us. Is
Baxter International Inc at UBS Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot